and Th17 but Enhances Regulatory T Cell Deficiency and Inhibition Suppresses Th1 Immunoproteasome Subunit LMP7

Marcus GroettrupKhalid W. Kalim, Michael Basler, Christopher J. Kirk andhttp://www.jimmunol.org/content/189/8/4182doi: 10.4049/jimmunol.1201183September 2012;J Immunol€2012; 189:4182-4193; Prepublished online 14MaterialSupplementary3.DC1.htmlhttp://www.jimmunol.org/content/suppl/2012/09/14/jimmunol.120118Referenceshttp://www.jimmunol.org/content/189/8/4182.full#ref-list-1This article cites 47 articles, 14 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  Robert W. Williams,et al.  Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.

[2]  Thomas Korn,et al.  IL-17 and Th17 Cells. , 2009, Annual review of immunology.

[3]  Agneta Karlsson,et al.  Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. , 2005, American journal of physiology. Gastrointestinal and liver physiology.

[4]  M. Groettrup,et al.  Proteasomes in immune cells: more than peptide producers? , 2010, Nature Reviews Immunology.

[5]  Dan R. Littman,et al.  Induction of Intestinal Th17 Cells by Segmented Filamentous Bacteria , 2009, Cell.

[6]  Bogdan Tanasa,et al.  Regulation of Th2 differentiation and Il4 locus accessibility. , 2006, Annual review of immunology.

[7]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[8]  T. Mcclanahan,et al.  IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. , 2006, The Journal of clinical investigation.

[9]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[10]  T. Mcclanahan,et al.  The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17–producing effector T helper cells in vivo , 2009, Nature Immunology.

[11]  R. D. Hatton,et al.  Developmental plasticity of Th17 and Treg cells. , 2009, Current opinion in immunology.

[12]  M. Groettrup,et al.  Prevention of Experimental Colitis by a Selective Inhibitor of the Immunoproteasome , 2010, The Journal of Immunology.

[13]  Alf Hamann,et al.  Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage? , 2009, Nature Reviews Immunology.

[14]  C. Benoist,et al.  How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. , 2009, Immunity.

[15]  Marcus Groettrup,et al.  Immunoproteasomes Down-Regulate Presentation of a Subdominant T Cell Epitope from Lymphocytic Choriomeningitis Virus1 , 2004, The Journal of Immunology.

[16]  R. D. Hatton,et al.  Interplay between the TH17 and TReg cell lineages: a (co-)evolutionary perspective , 2009, Nature Reviews Immunology.

[17]  M. Takashina,et al.  Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon‐γ for acquirement of the functional diversity responsible for antigen processing , 1994, FEBS letters.

[18]  E. Kalkhoven,et al.  Regulation of Treg functionality by acetylation-mediated Foxp3 protein stabilization. , 2010, Blood.

[19]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[20]  Khalid W. Kalim,et al.  A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis , 2009, Nature Medicine.

[21]  N. Varin‐Blank,et al.  A crosstalk between hSiah2 and Pias E3-ligases modulates Pias-dependent activation , 2007, Oncogene.

[22]  Warren Strober,et al.  Interactions among the transcription factors Runx1, RORγt and Foxp3 regulate the differentiation of interleukin 17–producing T cells , 2008, Nature Immunology.

[23]  P Jay,et al.  Specific inhibition of Stat3 signal transduction by PIAS3. , 1997, Science.

[24]  M. Dhodapkar,et al.  Increased Expression of Interleukin 23 p19 and p40 in Lesional Skin of Patients with Psoriasis Vulgaris , 2004, The Journal of experimental medicine.

[25]  Jonathan W. Yewdell,et al.  Immunoproteasomes Shape Immunodominance Hierarchies of Antiviral Cd8+ T Cells at the Levels of T Cell Repertoire and Presentation of Viral Antigens , 2001, The Journal of experimental medicine.

[26]  P M Kloetzel,et al.  Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes , 1994, The Journal of experimental medicine.

[27]  L. Kaer,et al.  Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. , 1998 .

[28]  J. O’Shea,et al.  Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. , 2010, Immunity.

[29]  A. Yoshimura,et al.  Foxp3 Inhibits RORγt-mediated IL-17A mRNA Transcription through Direct Interaction with RORγt*♦ , 2008, Journal of Biological Chemistry.

[30]  P. Kloetzel,et al.  Ubiquitin and proteasomes: Antigen processing by the proteasome , 2001, Nature Reviews Molecular Cell Biology.

[31]  H. Kinyamu,et al.  Proteasome Activity Modulates Chromatin Modifications and RNA Polymerase II Phosphorylation To Enhance Glucocorticoid Receptor-Mediated Transcription , 2007, Molecular and Cellular Biology.

[32]  R. Coffman,et al.  TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. , 1989, Annual review of immunology.

[33]  Yuelei Shen,et al.  TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function , 2008, Nature.

[34]  M. Groettrup,et al.  An Altered T Cell Repertoire in MECL-1-Deficient Mice1 , 2006, The Journal of Immunology.

[35]  P. Dijke,et al.  Negative regulation of TGF-β receptor/Smad signal transduction , 2007 .

[36]  S. Szabo,et al.  Molecular mechanisms regulating Th1 immune responses. , 2003, Annual review of immunology.

[37]  P. Alex,et al.  Distinct Cytokine Patterns Identified from Multiplex Profiles of Murine DSS and TNBS‐Induced Colitis , 2009, Inflammatory bowel diseases.

[38]  M. Leach,et al.  IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. , 2001, Immunity.

[39]  M. H. Lee,et al.  Th17 Responses Are Not Induced in Dextran Sodium Sulfate Model of Acute Colitis , 2011, Immune network.

[40]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[41]  Nathalie Arbour,et al.  Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation , 2007, Nature Medicine.

[42]  M. Groll,et al.  20S proteasome and its inhibitors: crystallographic knowledge for drug development. , 2007, Chemical reviews.

[43]  H. Mollenkopf,et al.  Targeting the proteasome: partial inhibition of the proteasome by bortezomib or deletion of the immunosubunit LMP7 attenuates experimental colitis , 2010, Gut.

[44]  K. Schwarz,et al.  Structural plasticity of the proteasome and its function in antigen processing. , 2001, Critical reviews in immunology.

[45]  M. van den Broek,et al.  Immunoproteasomes are essential for survival and expansion of T cells in virus‐infected mice , 2010, European journal of immunology.